The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Envafolimab combined with lenvatinib and gemcitabine plus cisplatin in advanced biliary tract cancer as first-line treatment: A single-arm, open-label, phase II study (ENLIGHTEN study).
 
Ming Kuang
No Relationships to Disclose
 
Lixia Xu
No Relationships to Disclose
 
Mengping Zhang
No Relationships to Disclose
 
Gaomin Zheng
No Relationships to Disclose
 
Chuankai Zhang
No Relationships to Disclose
 
Ying Zhang
No Relationships to Disclose
 
Tianhong Su
No Relationships to Disclose
 
Jifei Wang
No Relationships to Disclose
 
Fang Wang
No Relationships to Disclose
 
Fengjie Wang
No Relationships to Disclose
 
Huanwei Chen
No Relationships to Disclose